Cargando…
Correction: Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies
Correction for ‘Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies’ by Bo-Cheng Huang et al., Chem. Sci., 2021, DOI: 10.1039/D1SC01748A.
Autores principales: | Huang, Bo-Cheng, Lu, Yun-Chi, Liao, Jun-Min, Liu, Hui-Ju, Hong, Shih-Ting, Hsieh, Yuan-Chin, Chuang, Chih-Hung, Chen, Huei-Jen, Liao, Tzu-Yi, Ho, Kai-Wen, Wang, Yeng-Tseng, Cheng, Tian-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336449/ https://www.ncbi.nlm.nih.gov/pubmed/34377426 http://dx.doi.org/10.1039/d1sc90153b |
Ejemplares similares
-
Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies
por: Huang, Bo-Cheng, et al.
Publicado: (2021) -
Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains
por: Chen, I-Ju, et al.
Publicado: (2017) -
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy
por: Lin, Wen-Wei, et al.
Publicado: (2021) -
A molecular dynamics simulation study decodes the Zika virus NS5 methyltransferase bound to SAH and RNA analogue
por: Chuang, Chih-Hung, et al.
Publicado: (2018) -
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy
por: Lu, Yun-Chi, et al.
Publicado: (2019)